[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566548":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":19,"locations":29,"responsibleParty":42,"collaborators":44,"id":54,"slug":18,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":61,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":18,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":79,"whyStopped":18,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"prospective cervical cancer screening intervention","Evaluation of a cervical cancer screening outreach intervention using point-of-care High-Risk HPV (HPV-HR) tests on self-collected vaginal swabs",[12],"Other: HPV self sampling",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":18},"HPV self sampling","Selected women will perform a vaginal self-sampling using a swab",[9],null,[20,25],{"name":21,"role":22,"phone":23,"phoneExt":18,"email":24},"KARINE AMAT","CONTACT","0140256352","karine.amat@fondation-imea.org",{"name":26,"role":22,"phone":27,"phoneExt":18,"email":28},"Aïda BENALYCHERIF","0140256365","aida.benalycherif@fondation-imea.org",[30],{"facility":31,"status":18,"city":32,"state":18,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":18},"Hopital Avicenne","Bobigny","93000","France","FR",{"type":37,"coordinates":38},"Point",[39,40],2.45012,48.90982,{"lat":40,"lon":39},{"type":43,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[45,47,50,52],{"name":46,"class":6},"Hospital Avicenne",{"name":48,"class":49},"National Cancer Institute, France","OTHER_GOV",{"name":51,"class":6},"INSERM UMR S 1136",{"name":53,"class":49},"Institut National de la Santé Et de la Recherche Médicale, France","100566548",false,"NCT06656611","Mobile Outreach Screening of High-Risk Human Papillomavirus Infection in Women with Limited Access to Health Services in Seine-Saint-Denis (greater Paris Area, France)","PAPMOBILE: Mobile Outreach Screening of High-Risk Human Papillomavirus Infection in Women with Limited Access to Health Services in Seine-Saint-Denis (greater Paris Area, France)","PAPMOBILE","Inclusion Criteria:\n\n* \\- Women from 30 to 65 years of age presenting to the \" Bus Santé \" nonclinical testing unit, eligible to cervical cancer screening by an HPV-HR test\n* Women affiliated to the French social security or immigrants benefiting from the state medical aid program for undocumented immigrants (Aide Médicale d'Etat). The inclusion of people not affiliated to a social security system is an exception and depends on the decision of the Personal Protection Committee, if it is based on an expected benefit for these people of a nature to justify the foreseeable risk incurred.\n* The intervention is designed for vulnerable women with limited access to healthcare, including but not limited to:\n\n  * Women living in shelters and hostels, women living in the streets, in squats, hot-bedding arrangements, emergency social housing;\n  * Recent immigrants, documented or undocumented;\n  * Young adults from priority neighbourhoods,\n  * Isolated or marginalized women\n* Free, informed, written consent, signed by the person and the investigator at the latest on the day of inclusion and before any sampling carried out as part of the trial (article L1122-1-1 of the Public Health Code)\n\nThe Bus will operate in underprivileged neighbourhoods in the greater Paris area (eastern Seine-Saint-Denis department.\n\nExclusion Criteria:\n\n* Screened for cervical cancer by a PAP smear in the last 3 years or by an HPV test in the last 5 years,\n* Women on their period (haemoglobin inhibits PCRs)\n* Pregnancy in the 2nd and 3rd trimesters\n* Total hysterectomy; absence of a vagina\n* Women under guardianship\u002Ftutelage",true,"FEMALE","30 Years","65 Years",{"count":66,"type":67},700,"ESTIMATED","INTERVENTIONAL",[70],"NA","The study is a prospective cervical cancer screening intervention in the nonclinical setting of a mobile testing unit in a vehicle, using point-of-care HPV PCR tests with self-collected vaginal swabs.\n\nIt is designed for women with limited access to healthcare and prevention in underprivileged municipalities in the greater Paris area (Seine-Saint-Denis department, detailed in Annexe 3).\n\nHPV positive participants will receive counseiling and guidance to help them find a healthcare professional to take care of their needs",[73],"Women's Health: Cervical Neoplasm",[75,76,77,78],"HPV","cervical cancer","outreach intervention","vaginal self sampling","NOT_YET_RECRUITING","2024-10-23",{"date":82,"type":83},"2024-10-24","ACTUAL",{"date":85,"type":67},"2024-12-01",{"date":87,"type":67},"2026-07-30",{"name":5,"class":6},1]